ARCHIVES

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

This article is from The Cancer Letter archive.

Vol. 25 No. 44 | November 19, 1999

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

Panel Clear On Breast Conservation, Not On Adjuvant Therapy For Node

June 29, 1990

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004